Related Experiment Video

Updated: Aug 20, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

[Viral bronchiolitis and pneumopathies in infants]

J Brouard1, F Freymuth

  • 1Service de pédiatrie A, Centre hospitalier universitaire de Caen.

La Revue Du Praticien
|November 1, 1996
PubMed

Insights

Acute bronchiolitis, a common infant respiratory infection, usually resolves within days with supportive care. Treatments like oxygen, fluids, and inhaled beta-agonists are key, while inhaled corticosteroids may help with chronic wheezing.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Respiratory Medicine

Context:

  • Acute bronchiolitis is the most common severe lower-respiratory-tract infection in infants.
  • Most viral respiratory infections causing bronchiolitis are self-limited, with improvement in a few days.
  • Hospitalized infants often require supportive care, including oxygen, fluids, and potentially mechanical ventilation.

Purpose:

  • To outline the typical course and management of acute bronchiolitis in infants.
  • To review the evidence for various therapeutic interventions.
  • To guide clinical decision-making for this common childhood illness.

Summary:

  • Bronchiolitis management focuses on supportive care, including oxygen and fluid support.
  • A trial of aerosolized beta-2 agonists is recommended.
  • Systemic corticosteroids are not proven effective, but inhaled corticosteroids may reduce post-bronchiolitis chronic wheezing.
  • Ribavirin is an option for severe or high-risk cases.

Impact:

  • Provides a concise overview of current best practices for managing acute bronchiolitis.
  • Highlights the limited role of systemic corticosteroids and the potential benefit of inhaled corticosteroids.
  • Informs clinicians on appropriate supportive and pharmacological interventions for infants with bronchiolitis.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...